234 results on '"post-acute COVID-19"'
Search Results
2. Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)
- Author
-
Shionogi Inc. and Timothy Henrich, Professor of Medicine
- Published
- 2024
3. Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (PRECISION)
- Published
- 2024
4. Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice (UpcomingVoice)
- Published
- 2024
5. Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial
- Author
-
Medical College of Wisconsin and National Institutes of Health (NIH)
- Published
- 2024
6. Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (outSMART-LC)
- Author
-
Aerium Therapeutics, Patient-Led Research Collaborative, PolyBio Research Foundation, and Michael Peluso, MD, Assistant Professor, Medicine
- Published
- 2024
7. I Am Not the Same as I Was Before: A Qualitative Analysis of COVID-19 Survivors.
- Author
-
Duan, Emily, Garry, Kira, Horwitz, Leora, and Weerahandi, Himali
- Subjects
Chronic COVID-19 ,Long COVID ,Post-acute COVID-19 ,Qualitative study ,Humans ,COVID-19 ,SARS-CoV-2 ,Cohort Studies ,Quality of Life ,Survivors - Abstract
BACKGROUND: Little is known about the illness experience of patients long-term emotional and physical recovery from severe COVID-19 infection. This study aimed to expand upon the recovery process of COVID-19 survivors up to 6 months after hospital discharge. METHODS: Qualitative analysis of free-response answers from a cohort study of 152 patients ≥ 18 years hospitalized with laboratory-confirmed SARS-CoV-2 surveyed at 1-month post hospital discharge and 6-months post hospital discharge. Responses were analyzed with a grounded theory approach to identify overarching themes. RESULTS: Participants described persistent complications, both physical and mental, that have affected their recovery from COVID-19. Five overarching themes of post-acute patient experiences were generated: (1) an increased awareness of a mind and body connection, (2) feelings of premature aging, (3) an overall decline in quality of life, (4) a continued fear of infection, and (5) methods of coping. CONCLUSIONS: Patients described lasting changes to their mental health and overall quality of life in connection to physical complications after severe COVID-19 infection. Patients reports of their experience call for a greater awareness of the psychological aspects of COVID-19 recovery to provide both physical and psychological rehabilitation services. Additional resources such as education around re-infection and financial resources are needed.
- Published
- 2023
8. Neurobiology of Neuroimmune Encephalitic Disorders
- Author
-
Laje, Gonzalo, Schulze, Thomas G., Section editor, Tasman, Allan, editor, Riba, Michelle B., editor, Alarcón, Renato D., editor, Alfonso, César A., editor, Kanba, Shigenobu, editor, Lecic-Tosevski, Dusica, editor, Ndetei, David M., editor, Ng, Chee H., editor, and Schulze, Thomas G., editor
- Published
- 2024
- Full Text
- View/download PDF
9. Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops
- Published
- 2023
10. Persistent hiccups after acute COVID-19 successfully treated with chlorpromazine: a case report
- Author
-
Ireen Chanda Bwalya
- Subjects
Post-acute COVID-19 ,Persistent hiccup ,Epidemiology ,Drug treatment ,Chlorpromazine ,Diagnosis ,Medicine - Abstract
Abstract Introduction Hiccups are among the rare complications of COVID-19 infections. There are several published reports of persistent hiccups presenting during the acute COVID-19 period. However, there are very few published reports of persistent hiccups occurring in the post-acute COVID-19 period. Consequently, most clinicians may not be aware of this rare presentation. This case highlights an atypical presentation of persistent hiccups that manifested during the post-acute COVID -19 period that clinicians need to be aware of. The caseadds to the ever increasing body of knowledge about symptoms and signs associated with Severe Acute Respiratory Syndrome Corona Virus type 2 (SARS CoV-2) infection. Case presentation A 27 year old male black Zambian patient presented to the emergency department of our hospital with persistent hiccup, 35 days after the initial acute episode of COVID-19. This was associated with breathlessness. There were no other symptoms. He had no history of pulmonary, gastrointestinal, neurological disease or malignancy. He did not take any alcohol or smoke. He had never used any recreational drugs. He was employed as a monitoring and evaluation officer at one of the main COVID centres in the capital. On examination, the patient was anxious. Blood pressure was 141/82, pulse rate was 95 beats per minute, respiratory rate was 26 breaths per minute, temperature was 36.8C and oxygen saturation was 97% on room air. Systemic examination was normal. Chest X-ray and abdominal ultrasonography were normal. A rapid COVID-19 antigen test, and COVID-19 Polymerase Chain Reaction (PCR) test that were done the following day were negative. All other haematological and biochemical tests, including D-dimer and C-reactive protein (CRP), were also normal. A diagnosis of post-acute COVID-19 associated hiccups was made. The patient responded well to treatment with chlorpromazine 25 mg 8 hourly. The hiccups disappeared completely after the fourth dose of chlorpromazine. Conclusion This is one of the few published cases of COVID-19 associated persistent hiccups, occurring more than a month after the initial presentation. Most of the published cases report hiccups occurring in the acute COVID-19 period. Consequently, hiccups occurring in the post-acute COVID-19 period may not be attributable to COVID-19. This case has highlighted the need to consider post-acute COVID-19 in the differential diagnosis of persistent hiccup.
- Published
- 2024
- Full Text
- View/download PDF
11. Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome
- Author
-
Núria Guillén, Agnès Pérez-Millan, Neus Falgàs, Gema M. Lledó-Ibáñez, Lorena Rami, Jordi Sarto, Maria A. Botí, Cristina Arnaldos-Pérez, Raquel Ruiz-García, Laura Naranjo, Bàrbara Segura, Mircea Balasa, Roser Sala-Llonch, Albert Lladó, Sarah M. Gray, Jason K. Johannesen, Madeline M. Pantoni, Grant A. Rutledge, Ruta Sawant, Yi Wang, Luke S. Watson, Josep Dalmau, and Raquel Sanchez-Valle
- Subjects
Post-acute COVID-19 ,Cognitive symptoms ,MRI ,Cytokines ,Longitudinal study ,Medicine ,Science - Abstract
Abstract We aimed to characterize the cognitive profile of post-acute COVID-19 syndrome (PACS) patients with cognitive complaints, exploring the influence of biological and psychological factors. Participants with confirmed SARS-CoV-2 infection and cognitive complaints ≥ 8 weeks post-acute phase were included. A comprehensive neuropsychological battery (NPS) and health questionnaires were administered at inclusion and at 1, 3 and 6 months. Blood samples were collected at each visit, MRI scan at baseline and at 6 months, and, optionally, cerebrospinal fluid. Cognitive features were analyzed in relation to clinical, neuroimaging, and biochemical markers at inclusion and follow-up. Forty-nine participants, with a mean time from symptom onset of 10.4 months, showed attention-executive function (69%) and verbal memory (39%) impairment. Apathy (64%), moderate-severe anxiety (57%), and severe fatigue (35%) were prevalent. Visual memory (8%) correlated with total gray matter (GM) and subcortical GM volume. Neuronal damage and inflammation markers were within normal limits. Over time, cognitive test scores, depression, apathy, anxiety scores, MRI indexes, and fluid biomarkers remained stable, although fewer participants (50% vs. 75.5%; p = 0.012) exhibited abnormal cognitive evaluations at follow-up. Altered attention/executive and verbal memory, common in PACS, persisted in most subjects without association with structural abnormalities, elevated cytokines, or neuronal damage markers.
- Published
- 2024
- Full Text
- View/download PDF
12. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients
- Author
-
Adeel Nasrullah, Shiza Virk, Anam Javed, Aaisha Shah, Deeksha Ramanujam, Alisha Sharma, Laura Gutierrez, Kevin Nauer, Mindy Maggio, Yue Yin, Yousaf Bajwa, Tariq Cheema, and Briana Disilvio
- Subjects
Post-acute Sequelae of SARS-CoV-2 infection ,Long COVID ,Post-acute COVID-19 ,Pulmonary Rehabilitation ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background COVID-19 survivors may develop long-term symptoms of fatigue, dyspnea, mental health issues, and functional limitations: a condition termed post-acute sequelae of COVID-19 (PASC). Pulmonary rehabilitation (PR) is a recommended treatment for PASC; however, there is a lack of data regarding PR’s effect on multiple health indices and the factors that influence patient outcomes. The aim of our study is to evaluate the impact of pulmonary rehabilitation on functional and psychological parameters in patients diagnosed with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), thereby offering insights into the efficacy of such interventions in improving the quality of life and clinical outcomes for these individuals. Methods We extracted patient demographic, comorbidity, and outcome data from Allegheny Health Network’s electronic medical records. Functionality test results were compared before and after PR, including 6-minute walk test (6MWT), chair rise repetitions (CR reps), timed up and go test (TUG), gait speed (Rehab gait), modified medical research council scale (MMRC), shortness of breath questionnaire (SOBQ), hospital anxiety and depression scale (HADS) and chronic obstructive pulmonary disease assessment test (CAT) scores. Multiple regression analysis was done to evaluate the effect of comorbidities and patient factors on patient responses to PR. Results The 55 patients included in this study had a mean time of 4 months between the initial COVID-19 diagnosis and the subsequent PASC diagnosis. Following pulmonary rehabilitation (PR), significant improvements were observed across various metrics. The distance covered in the 6-minute walk test (6MWT) increased markedly from a pre-rehabilitation average of 895 feet (SD 290) to 1,300 feet (SD 335) post-rehabilitation, with a mean change of 405 feet (95% CI [333, 477]). Chair rise repetitions (CR reps) saw an increase from 9 (SD 3) reps to 13 (SD 3) reps, with a change of 4 reps (95% CI [3.7, 4.9]). The timed up and go test (TUG) time decreased significantly from 13 s (SD 5) to 10 s (SD 2), reflecting a mean reduction of 3 s (95% CI [-4.5, -2.5]). Rehabilitation gait speed improved from 1.0 m/s to 1.3 m/s, changing by 0.3 m/s (95% CI [0.2, 0.3]). The Modified Medical Research Council (MMRC) dyspnea scale showed a notable decrease from a mean of 2 (SD 1) to 1 (SD 1), a change of -1 (95% CI [-1.5, -1]). The Shortness of Breath Questionnaire (SOBQ) scores reduced significantly from 51 (SD 21) to 22 (SD 18), with a change of -29 (95% CI [-34, -23]). The Hospital Anxiety and Depression Scale (HADS) scores decreased from 11 (SD 7) to 8 (SD 7), a reduction of -4 (95% CI [-5, -2]). Lastly, the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) scores significantly dropped from 18 (SD 7) to 9 (SD 7), changing by -10 (95% CI [-11, -8]). However, the presence of hypertension, diabetes, chronic lung diseases, outpatient status, and receipt of specific pharmacologic treatments (decadron, decadron + remdesivir, and decadron + remdesivir + tocilizumab) were identified as factors associated with a poor response to PR. Conclusion Our study supports PR as an integrated model of care for PASC patients to improve several physical and mental health indices. The long-term effects of PR on patients’ functional status should be investigated in the future.
- Published
- 2024
- Full Text
- View/download PDF
13. Persistent hiccups after acute COVID-19 successfully treated with chlorpromazine: a case report.
- Author
-
Bwalya, Ireen Chanda
- Subjects
- *
HICCUPS , *SARS-CoV-2 , *COVID-19 pandemic , *CHLORPROMAZINE , *TREATMENT effectiveness - Abstract
Introduction: Hiccups are among the rare complications of COVID-19 infections. There are several published reports of persistent hiccups presenting during the acute COVID-19 period. However, there are very few published reports of persistent hiccups occurring in the post-acute COVID-19 period. Consequently, most clinicians may not be aware of this rare presentation. This case highlights an atypical presentation of persistent hiccups that manifested during the post-acute COVID -19 period that clinicians need to be aware of. The caseadds to the ever increasing body of knowledge about symptoms and signs associated with Severe Acute Respiratory Syndrome Corona Virus type 2 (SARS CoV-2) infection. Case presentation: A 27 year old male black Zambian patient presented to the emergency department of our hospital with persistent hiccup, 35 days after the initial acute episode of COVID-19. This was associated with breathlessness. There were no other symptoms. He had no history of pulmonary, gastrointestinal, neurological disease or malignancy. He did not take any alcohol or smoke. He had never used any recreational drugs. He was employed as a monitoring and evaluation officer at one of the main COVID centres in the capital. On examination, the patient was anxious. Blood pressure was 141/82, pulse rate was 95 beats per minute, respiratory rate was 26 breaths per minute, temperature was 36.8C and oxygen saturation was 97% on room air. Systemic examination was normal. Chest X-ray and abdominal ultrasonography were normal. A rapid COVID-19 antigen test, and COVID-19 Polymerase Chain Reaction (PCR) test that were done the following day were negative. All other haematological and biochemical tests, including D-dimer and C-reactive protein (CRP), were also normal. A diagnosis of post-acute COVID-19 associated hiccups was made. The patient responded well to treatment with chlorpromazine 25 mg 8 hourly. The hiccups disappeared completely after the fourth dose of chlorpromazine. Conclusion: This is one of the few published cases of COVID-19 associated persistent hiccups, occurring more than a month after the initial presentation. Most of the published cases report hiccups occurring in the acute COVID-19 period. Consequently, hiccups occurring in the post-acute COVID-19 period may not be attributable to COVID-19. This case has highlighted the need to consider post-acute COVID-19 in the differential diagnosis of persistent hiccup. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Identifying Long COVID Definitions, Predictors, and Risk Factors in the United States: A Scoping Review of Data Sources Utilizing Electronic Health Records.
- Author
-
Luke, Rayanne A., Shaw Jr., George, Saarunya, Geetha, and Mollalo, Abolfazl
- Subjects
POST-acute COVID-19 syndrome ,ELECTRONIC health records ,SCIENCE databases ,MEDLINE ,WEB databases ,ANTIGEN analysis - Abstract
This scoping review explores the potential of electronic health records (EHR)-based studies to characterize long COVID. We screened all peer-reviewed publications in the English language from PubMed/MEDLINE, Scopus, and Web of Science databases until 14 September 2023, to identify the studies that defined or characterized long COVID based on data sources that utilized EHR in the United States, regardless of study design. We identified only 17 articles meeting the inclusion criteria. Respiratory conditions were consistently significant in all studies, followed by poor well-being features (n = 14, 82%) and cardiovascular conditions (n = 12, 71%). Some articles (n = 7, 41%) used a long COVID-specific marker to define the study population, relying mainly on ICD-10 codes and clinical visits for post-COVID-19 conditions. Among studies exploring plausible long COVID (n = 10, 59%), the most common methods were RT-PCR and antigen tests. The time delay for EHR data extraction post-test varied, ranging from four weeks to more than three months; however, most studies considering plausible long COVID used a waiting period of 28 to 31 days. Our findings suggest a limited utilization of EHR-derived data sources in defining long COVID, with only 59% of these studies incorporating a validation step. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
- Author
-
Nasrullah, Adeel, Virk, Shiza, Javed, Anam, Shah, Aaisha, Ramanujam, Deeksha, Sharma, Alisha, Gutierrez, Laura, Nauer, Kevin, Maggio, Mindy, Yin, Yue, Bajwa, Yousaf, Cheema, Tariq, and Disilvio, Briana
- Subjects
POST-acute COVID-19 syndrome ,NEUROREHABILITATION ,CHRONIC obstructive pulmonary disease ,MEDICAL research ,WALKING speed ,MULTIPLE regression analysis ,CANCER fatigue - Abstract
Background: COVID-19 survivors may develop long-term symptoms of fatigue, dyspnea, mental health issues, and functional limitations: a condition termed post-acute sequelae of COVID-19 (PASC). Pulmonary rehabilitation (PR) is a recommended treatment for PASC; however, there is a lack of data regarding PR's effect on multiple health indices and the factors that influence patient outcomes. The aim of our study is to evaluate the impact of pulmonary rehabilitation on functional and psychological parameters in patients diagnosed with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), thereby offering insights into the efficacy of such interventions in improving the quality of life and clinical outcomes for these individuals. Methods: We extracted patient demographic, comorbidity, and outcome data from Allegheny Health Network's electronic medical records. Functionality test results were compared before and after PR, including 6-minute walk test (6MWT), chair rise repetitions (CR reps), timed up and go test (TUG), gait speed (Rehab gait), modified medical research council scale (MMRC), shortness of breath questionnaire (SOBQ), hospital anxiety and depression scale (HADS) and chronic obstructive pulmonary disease assessment test (CAT) scores. Multiple regression analysis was done to evaluate the effect of comorbidities and patient factors on patient responses to PR. Results: The 55 patients included in this study had a mean time of 4 months between the initial COVID-19 diagnosis and the subsequent PASC diagnosis. Following pulmonary rehabilitation (PR), significant improvements were observed across various metrics. The distance covered in the 6-minute walk test (6MWT) increased markedly from a pre-rehabilitation average of 895 feet (SD 290) to 1,300 feet (SD 335) post-rehabilitation, with a mean change of 405 feet (95% CI [333, 477]). Chair rise repetitions (CR reps) saw an increase from 9 (SD 3) reps to 13 (SD 3) reps, with a change of 4 reps (95% CI [3.7, 4.9]). The timed up and go test (TUG) time decreased significantly from 13 s (SD 5) to 10 s (SD 2), reflecting a mean reduction of 3 s (95% CI [-4.5, -2.5]). Rehabilitation gait speed improved from 1.0 m/s to 1.3 m/s, changing by 0.3 m/s (95% CI [0.2, 0.3]). The Modified Medical Research Council (MMRC) dyspnea scale showed a notable decrease from a mean of 2 (SD 1) to 1 (SD 1), a change of -1 (95% CI [-1.5, -1]). The Shortness of Breath Questionnaire (SOBQ) scores reduced significantly from 51 (SD 21) to 22 (SD 18), with a change of -29 (95% CI [-34, -23]). The Hospital Anxiety and Depression Scale (HADS) scores decreased from 11 (SD 7) to 8 (SD 7), a reduction of -4 (95% CI [-5, -2]). Lastly, the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) scores significantly dropped from 18 (SD 7) to 9 (SD 7), changing by -10 (95% CI [-11, -8]). However, the presence of hypertension, diabetes, chronic lung diseases, outpatient status, and receipt of specific pharmacologic treatments (decadron, decadron + remdesivir, and decadron + remdesivir + tocilizumab) were identified as factors associated with a poor response to PR. Conclusion: Our study supports PR as an integrated model of care for PASC patients to improve several physical and mental health indices. The long-term effects of PR on patients' functional status should be investigated in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (DSBLongCOVID)
- Author
-
Jonathann Kuo, MD, Medical Director
- Published
- 2023
17. Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection (PASC VQ)
- Author
-
4DMedical
- Published
- 2023
18. Population-Based Evaluation of Postacute Coronavirus Disease-2019 (COVID-19) Chronic Sequelae in Patients Who Tested Positive for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
- Author
-
Goldhaber, Nicole H, Ogan, W Scott, Greaves, Andrew, Tai-Seale, Ming, Sitapati, Amy, Longhurst, Christopher A, and Horton, Lucy E
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Emerging Infectious Diseases ,Clinical Research ,Pneumonia & Influenza ,Prevention ,Infectious Diseases ,Lung ,Pneumonia ,Good Health and Well Being ,chronic sequelae COVID-19 ,Long COVID ,post-acute COVID-19 ,Clinical sciences ,Medical microbiology - Abstract
The true incidence and comprehensive characteristics of Long Coronavirus Disease-19 (COVID-19) are currently unknown. This is the first population-based outreach study of Long COVID within an entire health system, conducted to determine operational needs to care for patients with Long COVID.
- Published
- 2022
19. High Plasma Osteopontin Levels Are Associated with Serious Post-Acute-COVID-19-Related Dyspnea.
- Author
-
Pappas, Apostolos G., Eleftheriou, Konstantinos, Vlahakos, Vassilios, Magkouta, Sophia F., Riba, Theofani, Dede, Konstantina, Siampani, Rafaela, Kompogiorgas, Steven, Polydora, Eftychia, Papalampidou, Athanasia, Loutsidi, Natasa-Eleni, Mantas, Nikolaos, Tavernaraki, Ekaterini, Exarchos, Demetrios, and Kalomenidis, Ioannis
- Subjects
- *
OSTEOPONTIN , *DYSPNEA , *COVID-19 , *MUSCLE fatigue , *LUNG volume measurements - Abstract
COVID-19 survivors commonly report persistent symptoms. In this observational study, we investigated the link between osteopontin (OPN) and post-acute COVID-19 symptoms and lung functional/imaging abnormalities. We recorded symptoms and lung imaging/functional data from previously hospitalized COVID-19 patients, who were followed for 4–84 weeks (122 patients/181 visits) post-symptom onset at our outpatient clinic. Circulating OPN was determined using ELISA. Plasma OPN levels were higher in symptomatic patients (compared with the asymptomatic ones); those with dyspnea (compared with those without dyspnea);those with a combination of serious symptoms, i.e., the presence of at least one of the following: dyspnea, fatigue and muscular weakness (compared with those with none of these symptoms); and those with dyspnea and m-MRC > 1 (compared with those with m-MRC = 0–1). Plasma OPN levels were inversely correlated with EQ-VAS (visual analog scale of the EQ-5D-5L health-related quality-of-life questionnaire) values. High-resolution CT or diffusion lung capacity (DLCO) findings were not related to circulating OPN. In the multiple logistic regression, the presence of symptoms, dyspnea, or the combination of serious symptoms were linked to female gender, increased BMI and pre-existing dyspnea (before the acute disease), while increased plasma OPN levels, female gender and pre-existing dyspnea with m-MRC > 1 were independently associated with severe post-COVID-19 dyspnea (m-MRC > 1). Using a correlation matrix to investigate multiple correlations between EQ-VAS, OPN and epidemiological data, we observed an inverse correlation between the OPN and EQ-VAS values. Increased circulating OPN was linked to the persistence of severe exertional dyspnea and impaired quality of life in previously hospitalized COVID-19 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. KNOWLEDGE OF COVID-19 AND POST-ACUTE COVID-19 AMONG PHARMACISTS IN MALAYSIA: A CROSS-SECTIONAL SURVEY.
- Author
-
Ballasingam, Ahtheemathurra, Islahudin, Farida, Abdul Aziz, Siti Azdiah, and Makmor-Bakry, Mohd
- Subjects
- *
COVID-19 , *PHARMACISTS - Abstract
Background: Coronavirus-19 has raised concerns as it causes post-acute symptoms among individuals. Appropriate knowledge, attitude, and practice with regards to COVID-19, and its post-acute complications among pharmacists is required for optimum management. Identifying the barriers, and facilitators encountered by pharmacists in providing care to these patients is also vital. The objectives of this study were to determine the knowledge, attitude, practice of COVID-19 and post-acute COVID-19, barriers, and facilitators among pharmacists. Materials & method: A cross-sectional survey was conducted among pharmacists registered and practicing in Malaysia with consent. An online survey was used to distribute the questionnaire using Google Form through convenient sampling. A questionnaire consisting of four sections was used in the study based on previous work. Data obtained in this study was interpreted using Statistical Package for Social Science (SPSS) (version 28; IBM Corp., Armonk, N.Y., USA). A p-value of <0.05 demonstrated statistically significant findings. Results: From a total of 405 pharmacists, the knowledge, attitude and practice score of the pharmacists was an average of 5.69 (±0.78) (maximum score 7), 3.56 (±0.63) (maximum score 4) and 3.38 (±0.61) (maximum score 4) respectively. A significant negative correlation was seen between COVID-19 knowledge, and attitude (r=- 0.16; p=0.001), while a positive correlation was seen between knowledge, and practice (r=0.11; p=0.025). The score for knowledge on post-acute COVID-19 was an average of 12.93 (±2.44) (maximum 20). 82.2% (n=333) respondents agreed that difficulty in accessing patient's clinical data was a barrier, whilst 95.6% (n=387) agreed support of healthcare system was regarded as the most common facilitator. Conclusion: There is a need for continuous education of COVID-19 as well as post-acute COVID-19 to ensure optimal management of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients.
- Author
-
Foresta, Andreana, Ojeda-Fernández, Luisa, Augurio, Claudia, Guanziroli, Cecilia, Tettamanti, Mauro, Macaluso, Giulia, Lauriola, Paolo, Nobili, Alessandro, Roncaglioni, Maria Carla, and Baviera, Marta
- Subjects
CONFIDENCE intervals ,POST-acute COVID-19 syndrome ,CROSS-sectional method ,AGE distribution ,PRIMARY health care ,RISK assessment ,COMPARATIVE studies ,SEX distribution ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,FATIGUE (Physiology) ,LOGISTIC regression analysis ,ODDS ratio ,LONGITUDINAL method ,DISEASE risk factors - Abstract
Background: Despite all the progress in the management of acute COVID-19, it is still not clear why some people continue to experience symptoms after recovery. Using data from a self-administered online survey, we assessed the prevalence and predictors of post-acute COVID-19 in an unselected population followed by GPs. Methods: Patients ≥18 years with a confirmed COVID-19 diagnosis were included. The survey collected information on demographics, risk factors, COVID-19 course and symptomatology. Fatigue and Quality of Life questionnaires were also administered. Descriptive statistics were used to describe patients' characteristics, stratified as acute and post-acute COVID-19. Logistic regression models were used to assess the association between clinical characteristics and post-acute COVID-19. Results: A total of 1108 surveys were analyzed. Nearly 29% of patients reported post-acute COVID-19. The more persistent symptoms were fatigue, memory and concentration impairment. Adjusted Odds Ratio (OR) showed a significantly higher probability of post-acute COVID-19 for women compared to men (OR 1.9, 95% CI 1.4-2.5), for age >50 years than ≤50 years (OR 1.6, 95% CI 1.2-2.2), for BMI > 25 compared to BMI ≤ 25 (OR 1.6, 95% CI 1.1-2.1) and those with autoimmune diseases, compared to those without (OR 1.8 95% CI 1.1-2.9). In addition, a significant association was found with COVID-19 hospitalization, anxiety and allergies. We found that post-acute COVID-19 patients showed a higher fatigue and a worst quality of life. Conclusions: These findings suggest the need for tailored personalized strategies to improve the management of patients with post-acute COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
- Author
-
Nuclear 215 Hospital of Shaanxi Province, Yanan Traditional Chinese Medicine Hospital, Shangluo Central Hospital, Xian QinHuang Hospital, Yulin No.2 Hospital, Hanzhong Central Hospital, Ankang Central Hospital, and Baoji High-tech Hospital
- Published
- 2023
23. Genetic Risk Factors for Multi-system Inflammatory Syndrome in Children and Pediatric Post COVID Condition (GRIP)
- Author
-
ZonMw: The Netherlands Organisation for Health Research and Development, University Medical Center Groningen, UMC Utrecht, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and epbuddingh, Dr. E.P. Buddingh
- Published
- 2023
24. Factors Associated with Postacute COVID-19 Syndrome Among Patients in Malaysia
- Author
-
Ahtheemathurra Ballasingam, Farida Islahudin, Siti Azdiah Abdul Aziz, and Mohd Makmor-Bakry
- Subjects
medication ,multiorgan ,post-acute covid-19 ,support ,symptoms ,Medicine - Abstract
Background: Post-acute COVID-19 is known to affect multiple organs. It is essential to determine factors that affect post-acute COVID-19 syndrome and medications needed by patients for optimized care. Methods: A prospective cohort study was conducted among patients recruited by stratified sampling from two COVID-19 hospitals in Malaysia. Patients were followed up for 6 months using a standard questionnaire to identify demographics, symptoms, medications taken, and factors associated with post-acute COVID-19 syndrome. Results: A total of 388 were successfully followed up. The most frequently reported symptom was respiratory symptoms (N = 168, 43.30%), of which cough (N = 134, 34.54%) was the most common. After 12 weeks of follow-up, respiratory syndrome (N = 56,14.43%) was frequently reported, of which cough (N = 41, 10.57%) was the most common. For respiratory syndrome, patients were commonly managed with diphenhydramine cough suppressants (N = 6, 1.55%, month 4) and metered dose inhaler (MDI) salbutamol (N = 7, 1.8%, month 4). The risk factors for post-acute COVID-19 syndrome were increased by 1.02 times (95% CI: 1.01, 1.04) with each advanced year of age and 2.87 times (95%CI: 1.51–5.48) in the presence of co-morbidities. Conclusions: Post-acute COVID-19 causes multiorgan involvement, and symptoms may remain for months, with patients taking various medications. Patients with risk factors should be monitored closely for post-acute COVID-19 symptoms.
- Published
- 2023
- Full Text
- View/download PDF
25. Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors (SYNPOCov)
- Author
-
GOEHRINGER François, Principal Investigator, clinical physician, Infectious Diseases department
- Published
- 2022
26. Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19 (CCTLongCOVID)
- Author
-
Jon Andoni Duñabeitia, Director of Research Center
- Published
- 2022
27. Personalized Computerized Training Program for Cognitive Dysfunction After COVID-19
- Author
-
Jon Andoni Duñabeitia, Principal Investigator
- Published
- 2022
28. Factors Associated with Postacute COVID-19 Syndrome Among Patients in Malaysia.
- Author
-
Ballasingam, Ahtheemathurra, Islahudin, Farida, Aziz, Siti Azdiah Abdul, and Makmor-Bakry, Mohd
- Subjects
RISK assessment ,STATISTICAL significance ,POST-acute COVID-19 syndrome ,MULTIPLE regression analysis ,DESCRIPTIVE statistics ,LONGITUDINAL method ,ODDS ratio ,DIPHENHYDRAMINE ,NEBULIZERS & vaporizers ,ALBUTEROL ,CONFIDENCE intervals ,DATA analysis software ,COVID-19 ,EVALUATION ,DISEASE risk factors - Abstract
Background: Post-acute COVID-19 is known to affect multiple organs. It is essential to determine factors that affect post-acute COVID-19 syndrome and medications needed by patients for optimized care. Methods: A prospective cohort study was conducted among patients recruited by stratified sampling from two COVID-19 hospitals in Malaysia. Patients were followed up for 6 months using a standard questionnaire to identify demographics, symptoms, medications taken, and factors associated with post-acute COVID-19 syndrome. Results: A total of 388 were successfully followed up. The most frequently reported symptom was respiratory symptoms (N = 168, 43.30%), of which cough (N = 134, 34.54%) was the most common. After 12 weeks of follow-up, respiratory syndrome (N = 56,14.43%) was frequently reported, of which cough (N = 41, 10.57%) was the most common. For respiratory syndrome, patients were commonly managed with diphenhydramine cough suppressants (N = 6, 1.55%, month 4) and metered dose inhaler (MDI) salbutamol (N = 7, 1.8%, month 4). The risk factors for post-acute COVID-19 syndrome were increased by 1.02 times (95% CI: 1.01, 1.04) with each advanced year of age and 2.87 times (95%CI: 1.51-5.48) in the presence of co-morbidities. Conclusions: Post-acute COVID-19 causes multiorgan involvement, and symptoms may remain for months, with patients taking various medications. Patients with risk factors should be monitored closely for post-acute COVID-19 symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Identifying Long COVID Definitions, Predictors, and Risk Factors in the United States: A Scoping Review of Data Sources Utilizing Electronic Health Records
- Author
-
Rayanne A. Luke, George Shaw, Geetha Saarunya, and Abolfazl Mollalo
- Subjects
electronic health records ,long COVID ,phenotypes ,post-acute COVID-19 ,Information technology ,T58.5-58.64 - Abstract
This scoping review explores the potential of electronic health records (EHR)-based studies to characterize long COVID. We screened all peer-reviewed publications in the English language from PubMed/MEDLINE, Scopus, and Web of Science databases until 14 September 2023, to identify the studies that defined or characterized long COVID based on data sources that utilized EHR in the United States, regardless of study design. We identified only 17 articles meeting the inclusion criteria. Respiratory conditions were consistently significant in all studies, followed by poor well-being features (n = 14, 82%) and cardiovascular conditions (n = 12, 71%). Some articles (n = 7, 41%) used a long COVID-specific marker to define the study population, relying mainly on ICD-10 codes and clinical visits for post-COVID-19 conditions. Among studies exploring plausible long COVID (n = 10, 59%), the most common methods were RT-PCR and antigen tests. The time delay for EHR data extraction post-test varied, ranging from four weeks to more than three months; however, most studies considering plausible long COVID used a waiting period of 28 to 31 days. Our findings suggest a limited utilization of EHR-derived data sources in defining long COVID, with only 59% of these studies incorporating a validation step.
- Published
- 2024
- Full Text
- View/download PDF
30. Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome
- Author
-
Guillén, Núria, Pérez-Millan, Agnès, Falgàs, Neus, Lledó-Ibáñez, Gema M., Rami, Lorena, Sarto, Jordi, Botí, Maria A., Arnaldos-Pérez, Cristina, Ruiz-García, Raquel, Naranjo, Laura, Segura, Bàrbara, Balasa, Mircea, Sala-Llonch, Roser, Lladó, Albert, Gray, Sarah M., Johannesen, Jason K., Pantoni, Madeline M., Rutledge, Grant A., Sawant, Ruta, Wang, Yi, Watson, Luke S., Dalmau, Josep, and Sanchez-Valle, Raquel
- Published
- 2024
- Full Text
- View/download PDF
31. Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation.
- Author
-
Cecchetto, Antonella, Guarnieri, Gabriella, Torreggiani, Gianpaolo, Vianello, Andrea, Baroni, Giulia, Palermo, Chiara, Bertagna De Marchi, Leonardo, Lorenzoni, Giulia, Bartolotta, Patrizia, Bertaglia, Emanuele, Donato, Filippo, Aruta, Patrizia, Iliceto, Sabino, and Mele, Donato
- Subjects
- *
GLOBAL longitudinal strain , *DYSPNEA , *COVID-19 , *PULMONARY function tests , *BODY mass index - Abstract
Post-acute COVID-19 is characterized by the persistence of dyspnea, but the pathophysiology is unclear. We evaluated the prevalence of dyspnea during follow-up and factors at admission and follow-up associated with dyspnea persistence. After five months from discharge, 225 consecutive patients hospitalized for moderate to severe COVID-19 pneumonia were assessed clinically and by laboratory tests, echocardiography, six-minute walking test (6MWT), and pulmonary function tests. Fifty-one patients reported persistent dyspnea. C-reactive protein (p = 0.025, OR 1.01 (95% CI 1.00–1.02)) at admission, longer duration of hospitalization (p = 0.005, OR 1.05 (95% CI 1.01–1.10)) and higher body mass index (p = 0.001, OR 1.15 (95% CI 1.06–1.28)) were independent predictors of dyspnea. Absolute drop in SpO2 at 6MWT (p = 0.001, OR 1.37 (95% CI 1.13–1.69)), right ventricular (RV) global longitudinal strain (p = 0.016, OR 1.12 (95% CI 1.02–1.25)) and RV global longitudinal strain/systolic pulmonary artery pressure ratio (p = 0.034, OR 0.14 (95% CI 0.02–0.86)) were independently associated with post-acute COVID-19 dyspnea. In conclusion, dyspnea is present in many patients during follow-up after hospitalization for COVID-19 pneumonia. While higher body mass index, C-reactive protein at admission, and duration of hospitalization are predictors of persistent dyspnea, desaturation at 6MWT, and echocardiographic RV dysfunction are associated with this symptom during the follow-up period. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Persisting and new onset symptomatology and determinants of functional limitation of post acute COVID-19 syndrome cases- A study from a Northern District of Kerala
- Author
-
Anuradha Thalian Chathoth, Naveen Anaswara, Arjun Chathoth Meethal, Jayasree Vasudevan, and Parvathi V Gopal
- Subjects
functional impairment ,new onset & persisting symptoms ,pcfs scale ,post-acute covid-19 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: COVID-19 disease has a wide range of persisting and new onset clinical manifestations even long after the acute phase. This study was conducted to identify the persisting and new onset symptomatology of post-COVID-19 syndrome patients from clinics in urban and peri-urban Kozhikode, South India, as well as to grade their functional limitation; assess the determinants and predictors. Material and Methods: A cross-sectional study was conducted among 938 subjects attending the post-COVID clinics. Symptom profile, functional assessment, and limitation grading were done using the Post-COVID-19 Functional Status (PCFS) scale. Statistical analyses were done using the SPSS ver.20. Results: Mean age was 41.50 ± 16.90 years. Fever, anosmia, dysgeusia, headache, and myalgia were the common acute COVID-19 symptoms (505,54%; 433,46.3%; 420,44.9%; 323,34.4%; 252,26.9%, respectively). Post-COVID-19, common persisting symptoms were myalgia (167,17.8%), fatigue (149,15.9%), dyspnea (113,12%), and headache (85,9.1%); the common new onset symptoms were shortness of breath and fatigue (228,24.3% and 220,23.4%, respectively). A total of 91 cases (9.7%) had post-COVID sleep disturbances; 16 (1.7%) had symptoms of anxiety and depressive thoughts. PCFS grading showed that 552 (63.8%) had negligible limitations (Grade I). Only one person had Grade IV limitation. Significant association (p < 0.05) was found between functional impairment grading by PCFS and age, gender, locality, type of family, duration of hospitalization, duration of unemployment following illness, source of infection, diabetes mellitus, and hypertension. Male gender, married status, CAD, and smoking had significant higher risks; urban locality and hospitalization decreased the risk. Conclusions: SARS-CoV-2 cases have persistent and new onset symptoms and some degree of functional impairment post-COVID. Significant association was identified for various sociodemographic and clinical variables with the PCFS functional impairment grading.
- Published
- 2023
- Full Text
- View/download PDF
33. High Plasma Osteopontin Levels Are Associated with Serious Post-Acute-COVID-19-Related Dyspnea
- Author
-
Apostolos G. Pappas, Konstantinos Eleftheriou, Vassilios Vlahakos, Sophia F. Magkouta, Theofani Riba, Konstantina Dede, Rafaela Siampani, Steven Kompogiorgas, Eftychia Polydora, Athanasia Papalampidou, Natasa-Eleni Loutsidi, Nikolaos Mantas, Ekaterini Tavernaraki, Demetrios Exarchos, and Ioannis Kalomenidis
- Subjects
osteopontin ,long COVID ,post-acute COVID-19 ,SARS-CoV-2 ,dyspnea ,quality of life ,Medicine - Abstract
COVID-19 survivors commonly report persistent symptoms. In this observational study, we investigated the link between osteopontin (OPN) and post-acute COVID-19 symptoms and lung functional/imaging abnormalities. We recorded symptoms and lung imaging/functional data from previously hospitalized COVID-19 patients, who were followed for 4–84 weeks (122 patients/181 visits) post-symptom onset at our outpatient clinic. Circulating OPN was determined using ELISA. Plasma OPN levels were higher in symptomatic patients (compared with the asymptomatic ones); those with dyspnea (compared with those without dyspnea);those with a combination of serious symptoms, i.e., the presence of at least one of the following: dyspnea, fatigue and muscular weakness (compared with those with none of these symptoms); and those with dyspnea and m-MRC > 1 (compared with those with m-MRC = 0–1). Plasma OPN levels were inversely correlated with EQ-VAS (visual analog scale of the EQ-5D-5L health-related quality-of-life questionnaire) values. High-resolution CT or diffusion lung capacity (DLCO) findings were not related to circulating OPN. In the multiple logistic regression, the presence of symptoms, dyspnea, or the combination of serious symptoms were linked to female gender, increased BMI and pre-existing dyspnea (before the acute disease), while increased plasma OPN levels, female gender and pre-existing dyspnea with m-MRC > 1 were independently associated with severe post-COVID-19 dyspnea (m-MRC > 1). Using a correlation matrix to investigate multiple correlations between EQ-VAS, OPN and epidemiological data, we observed an inverse correlation between the OPN and EQ-VAS values. Increased circulating OPN was linked to the persistence of severe exertional dyspnea and impaired quality of life in previously hospitalized COVID-19 patients.
- Published
- 2024
- Full Text
- View/download PDF
34. Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome.
- Author
-
Sorokina, Ekaterina, Pautova, Alisa, Fatuev, Oleg, Zakharchenko, Vladislav, Onufrievich, Alexander, Grechko, Andrey, Beloborodova, Natalia, and Chernevskaya, Ekaterina
- Subjects
- *
BLOOD cell count , *COVID-19 pandemic , *DYSBIOSIS , *COVID-19 , *FUMARATES , *GUT microbiome - Abstract
Post-COVID-19 syndrome is a complex of different symptoms, which results in a multisystemic impairment after the suffering from COVID-19 infection. The aim of the study was to reveal the clinical, laboratory, and gut disorders in patients with post-COVID-19 syndrome (n = 39) before and after taking part in the 14-day complex program of rehabilitation. A complete blood count, coagulation test, blood chemistry, biomarkers, and metabolites in serum samples, and gut dysbiosis were revealed in patients on the day of admission and after 14-day rehabilitation, in comparison with the variables of healthy volunteers (n = 48) or with reference ranges. On the day of discharge, patients noted an improvement in respiratory function, general well-being, and mood. At the same time, the levels of some metabolic (4-hydroxybenzoic, succinic, fumaric acids) and inflammatory (interleukin-6) variables, which were increased on admission, did not reach the level of healthy people during the rehabilitation program. Taxonomy disbalance was observed in patients' feces, namely, a high level of total bacterial mass, a decrease in the number of Lactobacillus spp., and an increase in pro-inflammatory microorganisms. The authors suggest that the post-COVID-19 rehabilitation program should be personalized, considering the patient's state together with not only the baseline levels of biomarkers, but also with the individual taxonomy of the gut microbiota. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Effect of Vaccination on Platelet Mitochondrial Bioenergy Function of Patients with Post-Acute COVID-19.
- Author
-
Gvozdjáková, Anna, Kucharská, Jarmila, Rausová, Zuzana, Lopéz-Lluch, Guillermo, Navas, Plácido, Palacka, Patrik, Bartolčičová, Barbora, and Sumbalová, Zuzana
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *VACCINATION , *MITOCHONDRIA , *BLOOD platelets , *THROMBOPOIETIN receptors , *RESPIRATION , *AVIAN influenza - Abstract
Background: Mitochondrial dysfunction and redox cellular imbalance indicate crucial function in COVID-19 pathogenesis. Since 11 March 2020, a global pandemic, health crisis and economic disruption has been caused by SARS-CoV-2 virus. Vaccination is considered one of the most effective strategies for preventing viral infection. We tested the hypothesis that preventive vaccination affects the reduced bioenergetics of platelet mitochondria and the biosynthesis of endogenous coenzyme Q10 (CoQ10) in patients with post-acute COVID-19. Material and Methods: 10 vaccinated patients with post-acute COVID-19 (V + PAC19) and 10 unvaccinated patients with post-acute COVID-19 (PAC19) were included in the study. The control group (C) consisted of 16 healthy volunteers. Platelet mitochondrial bioenergy function was determined with HRR method. CoQ10, γ-tocopherol, α-tocopherol and β-carotene were determined by HPLC, TBARS (thiobarbituric acid reactive substances) were determined spectrophotometrically. Results: Vaccination protected platelet mitochondrial bioenergy function but not endogenous CoQ10 levels, in patients with post-acute COVID-19. Conclusions: Vaccination against SARS-CoV-2 virus infection prevented the reduction of platelet mitochondrial respiration and energy production. The mechanism of suppression of CoQ10 levels by SARS-CoV-2 virus is not fully known. Methods for the determination of CoQ10 and HRR can be used for monitoring of mitochondrial bioenergetics and targeted therapy of patients with post-acute COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors.
- Author
-
Apostolo, Daria, D'Onghia, Davide, Tonello, Stelvio, Minisini, Rosalba, Baricich, Alessio, Gramaglia, Carla, Patrucco, Filippo, Zeppegno, Patrizia, Acquaviva, Antonio, Balbo, Piero Emilio, Castello, Luigi Mario, Cappellano, Giuseppe, Chiocchetti, Annalisa, Gerevini, Chiara, Giordano, Mara, Laaguid, Fatiha, Manfredi, Marcello, Raineri, Davide, Rigamonti, Cristina, and Rolla, Roberta
- Subjects
- *
BALDNESS , *COVID-19 , *LOGISTIC regression analysis , *HOSPITAL admission & discharge , *CARBOXYHEMOGLOBIN , *LUNG volume measurements - Abstract
Post-acute conditions after coronavirus disease 2019 (COVID-19) are quite common, although the underlying pathogenetic mechanisms leading to these conditions are not yet completely understood. In this prospective observational study, we aimed to test the hypothesis that Growth Arrest-Specific 6 (Gas6) and its soluble receptors, Axl (sAxl) and MerTK (sMer), might be implicated. A total of 263 subjects underwent a structured clinical evaluation one year after their hospital discharge for COVID-19, and they consented to donate a blood sample to measure their circulating Gas6, sAxl, and sMer levels. A total of 98 (37.3%) post-COVID-19 subjects complained of at least one residual physical symptom one year after their hospital discharge. Univariate analysis revealed that sAxl was marginally associated with residual symptoms, but at the level of logistic regression analysis, only the diffusing capacity of the lungs for carbon monoxide (DLCO) (OR 0.98, CI 95%: 0.96–0.99; p = 0.007) and the female sex (OR 2.49, CI 95%: 1.45–4.28; p = 0.001) were independently associated with long-lasting symptoms. A total of 69 (26.2%) subjects had hair loss. At the level of univariate analysis, Gas6, sAxl, DLCO, and the female gender were associated with its development. In a logistic regression analysis model, Gas6 (OR 0.96, CI 95%: 0.92–0.99; p = 0.015) and sAxl (OR 0.98, CI 95%; 0.97–1.0; p = 0.014), along with the female sex (OR 6.58, CI 95%: 3.39–12.78; p = 0.0001), were independent predictors of hair loss. Decreased levels of Gas6 and sAxl were associated with a history of hair loss following COVID-19. This was resolved spontaneously in most patients, although 23.7% complained of persistent hair loss one year after hospital discharge. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome
- Author
-
Zachariou A, Sapouna V, Kaltsas A, Dimitriadis F, Douvli E, Champilomatis I, Kounavou C, Papatsoris A, Tsounapi P, Takenaka A, and Sofikitis N
- Subjects
post-acute covid-19 ,quality of life ,aua-oab tool ,overactive bladder ,nocturia ,Medicine (General) ,R5-920 - Abstract
Athanasios Zachariou,1,2 Vagia Sapouna,2 Aris Kaltsas,1 Fotios Dimitriadis,3 Erriketi Douvli,1 Ioannis Champilomatis,1 Chrysanthi Kounavou,1 Athanasios Papatsoris,4 Panagiota Tsounapi,5 Atsushi Takenaka,5 Nikolaos Sofikitis1 1Department of Urology, University of Ioannina, Ioannina, Greece; 2Physical Medicine and Rehabilitation Centre EU PRATTEIN, Volos, Greece; 3 1st Department of Urology, Aristotle University of Thessaloniki, Thessaloniki, Greece; 4 2nd Department of Urology, Sismanogleion General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; 5Department of Urology, Faculty of Medicine, Tottori University, Yonago, JapanCorrespondence: Athanasios Zachariou, Department of Urology, University of Ioannina, 3 Spyridi Street, Volos, 38221, Greece, Tel +302421026937, Fax +302421026932, Email zahariou@otenet.grPurpose: Coronavirus disease (COVID-19) is a multi-organ viral infection with many manifestations. However, its impact on the genitourinary system is nowadays under investigation. This study aimed to evaluate the consequences on bladder function in patients suffering from post-acute COVID-19 syndrome (PACS) transferred to inpatient rehabilitation for long-term care after initial treatment for COVID-19 pathophysiology.Materials and Methods: All the patients were initially asked the question (after having recovered from the acute stage of COVID-19 disease): “Have you noticed a sudden, uncontrolled need to urinate and sometimes a urine leakage accompanying the voiding desire?” Sixty-six out of 147 patients responded positively to this question and were assessed with the AUA Urology Care Foundation Overactive Bladder Assessment Tool (AUA-OAB-tool). All included men were evaluated with the IPSS score.Results: The median age of patients was 59.5 (range 44– 72). We identified 44 patients with newly diagnosed OAB (Group A; post-COVID assessment) and 22 with worsening OAB symptoms (Group B). The mean symptom score ± standard deviation in Group A patients was 18.25 ± 2.11 (using the above AUA OAB tool). In the patients of Group B, there was an increase in the above score from 10.43 ± 1.52 (pre-COVID condition) to 17.87 ± 1.89 (post-COVID assessment). In patients of Group A, the total quality of life (QOL) score was 17.74 ± 2.34. Patients in Group B presented an escalation in total QOL score from 9.04 ± 1.41 (pre-COVID) to 18.84 ± 1.96 (post-COVID condition). There was no statistically significant difference in symptoms and QOL scores between men and women in groups A and B. There were 11 men in Group A and 5 in Group B with an IPSS score > 20.Conclusion: OAB symptoms may be essential to PACS syndrome and influence quality of life, delaying full recovery.Keywords: post-acute COVID-19, quality of life, AUA-OAB tool, overactive bladder, nocturia
- Published
- 2022
38. Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study.
- Author
-
Chen, Shanquan, Cardinal, Rudolf N., Gräf, Stefan, Auckland, Kathryn, O'Brien, John T., and Underwood, Benjamin R.
- Subjects
- *
DEMENTIA patients , *SARS-CoV-2 , *PROPORTIONAL hazards models , *COVID-19 ,MORTALITY risk factors - Abstract
Background: Persisting symptoms and increased mortality after SARS–CoV–2 infection has been described in COVID-19 survivors. Objective: We examined longer-term mortality in patients with dementia and SARS-CoV-2 infection. Methods: A retrospective matched case-control study of 165 patients with dementia who survived an acute hospital admission with COVID-19 infection, and 1325 patients with dementia who survived a hospital admission but without SARS-CoV-2 infection. Potential risk factors investigated included socio-demographic factors, clinical features, and results of investigations. Data were fitted using a Cox proportional hazard model. Results: Compared to patients with dementia but without SARS-CoV-2 infection, people with dementia and SARS-CoV-2 infection had a 4.4-fold risk of death (adjusted hazard ratio [aHR] = 4.44, 95% confidence interval [CI] 3.13–6.30) even beyond the acute phase of infection. This excess mortality could be seen up to 125 days after initial recovery but was not elevated beyond this time. Risk factors for COVID-19-associated mortality included prescription of antipsychotics (aHR = 3.06, 95% CI 1.40–6.69) and benzodiazepines (aHR = 3.00, 95% CI 1.28–7.03). Abnormalities on investigation associated with increased mortality included high white cell count (aHR = 1.21, 95% CI 1.04–1.39), higher absolute neutrophil count (aHR = 1.28, 95% CI 1.12–1.46), higher C-reactive protein (aHR = 1.01, 95% CI 1.00–1.02), higher serum sodium (aHR = 1.09, 95% CI 1.01–1.19), and higher ionized calcium (aHR = 1.03, 95% CI 1.00–1.06). The post-acute COVID mortality could be modeled for the first 120 days after recovery with a balanced accuracy of 87.2%. Conclusion: We found an increased mortality in patients with dementia beyond the acute phase of illness. We identified several investigation results associated with increased mortality, and increased mortality in patients prescribed antipsychotics or benzodiazepines. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Persisting and New Onset Symptomatology and Determinants of Functional Limitation of Post Acute COVID-19 Syndrome Cases- A Study from a Northern District of Kerala.
- Author
-
Chathoth, Anuradha Thalian, Anaswara, Naveen, Meethal, Arjun Chathoth, Vasudevan, Jayasree, and Gopal, Parvathi V.
- Subjects
- *
STATISTICS , *SOCIAL determinants of health , *FEVER , *TASTE disorders , *MYALGIA , *POST-acute COVID-19 syndrome , *FUNCTIONAL status , *CROSS-sectional method , *HEALTH status indicators , *RISK assessment , *DYSPNEA , *SLEEP disorders , *QUALITY of life , *DESCRIPTIVE statistics , *SMELL disorders , *MENTAL depression , *DATA analysis , *DATA analysis software , *HEADACHE , *FATIGUE (Physiology) , *ANXIETY , *SOCIODEMOGRAPHIC factors , *SYMPTOMS - Abstract
Background: COVID-19 disease has a wide range of persisting and new onset clinical manifestations even long after the acute phase. This study was conducted to identify the persisting and new onset symptomatology of post-COVID-19 syndrome patients from clinics in urban and peri-urban Kozhikode, South India, as well as to grade their functional limitation; assess the determinants and predictors. Material and Methods: A cross-sectional study was conducted among 938 subjects attending the post-COVID clinics. Symptom profile, functional assessment, and limitation grading were done using the Post-COVID-19 Functional Status (PCFS) scale. Statistical analyses were done using the SPSS ver.20. Results: Mean age was 41.50 ± 16.90 years. Fever, anosmia, dysgeusia, headache, and myalgia were the common acute COVID-19 symptoms (505,54%; 433,46.3%; 420,44.9%; 323,34.4%; 252,26.9%, respectively). Post-COVID-19, common persisting symptoms were myalgia (167,17.8%), fatigue (149,15.9%), dyspnea (113,12%), and headache (85,9.1%); the common new onset symptoms were shortness of breath and fatigue (228,24.3% and 220,23.4%, respectively). A total of 91 cases (9.7%) had post-COVID sleep disturbances; 16 (1.7%) had symptoms of anxiety and depressive thoughts. PCFS grading showed that 552 (63.8%) had negligible limitations (Grade I). Only one person had Grade IV limitation. Significant association (p < 0.05) was found between functional impairment grading by PCFS and age, gender, locality, type of family, duration of hospitalization, duration of unemployment following illness, source of infection, diabetes mellitus, and hypertension. Male gender, married status, CAD, and smoking had significant higher risks; urban locality and hospitalization decreased the risk. Conclusions: SARS-CoV-2 cases have persistent and new onset symptoms and some degree of functional impairment post-COVID. Significant association was identified for various sociodemographic and clinical variables with the PCFS functional impairment grading. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. Diabetes mellitus and the risk of post‐acute COVID‐19 hospitalizations—a nationwide cohort study.
- Author
-
Nørgård, Bente Mertz, Zegers, Floor Dijkstra, Juhl, Claus Bogh, Kjeldsen, Jens, and Nielsen, Jan
- Subjects
- *
COVID-19 , *CONFIDENCE intervals , *POST-acute COVID-19 syndrome , *DIABETES , *RISK assessment , *HOSPITAL care , *DESCRIPTIVE statistics , *LONGITUDINAL method , *PROPORTIONAL hazards models , *DISEASE risk factors - Abstract
Aims: This cohort study, based on Danish health registers, examined the post‐acute consequences of hospitalization for COVID‐19 in patients with diabetes. Methods: The study population comprised all Danish citizens (≥18 years old) who had diabetes when the pandemic started. A patient was exposed if he/she had a hospitalization with COVID‐19 after 1 March 2020. A patient was unexposed when he/she was not hospitalized with COVID‐19 between 1 March 2020 and the end of follow‐up (4 January 2022), or the first registered event of interest. The outcomes included post‐COVID‐19 hospitalizations and death. We used a Cox proportional hazards model with time varying exposure estimating the hazards ratio (HR) to analyze if the hazard for an outcome of interest was impacted by being hospitalized with COVID‐19. Results: In patients with type 1 diabetes, 101 were hospitalized with COVID‐19, and 25,459 were not. We did not have sufficient statistical power to identify differences in risk for those with type 1 diabetes. In type 2 diabetes, 1515 were hospitalized with COVID‐19, and 95,887 were not. The adjusted HRs of post‐acute hospitalization for respiratory diseases and infections were 1.71 (95% CI 1.45–2.03) and 1.87 (95% CI 1.61–2.18), respectively. The HR of death was 2.05 (95% CI 1.73–2.43). Patients with uncertain type had results similar to those with type 2 diabetes. Conclusions/Interpretation: In type 2 diabetes and diabetes of uncertain type, hospitalization with COVID‐19 was associated with an increased risk of post‐acute hospitalization for respiratory diseases, infections and death. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. Cardiovascular Disease in Post-Acute COVID-19 Syndrome: A Comprehensive Review of Pathophysiology and Diagnosis Approach.
- Author
-
Kusumawardhani, Nuraini Yasmin, Putra, Iwan Cahyo Santosa, Kamarullah, William, Afrianti, Rien, Pramudyo, Miftah, Iqbal, Mohammad, Prameswari, Hawani Sasmaya, Achmad, Chaerul, Tiksnadi, Badai Bhatara, and Akbar, Mohammad Rizki
- Abstract
Long COVID or post-acute Coronavirus disease 2019 (COVID-19), a malady defined by the persistence of COVID-19 symptoms for weeks or even months, is expected to affect the lives of millions of individuals worldwide significantly. Cardiopulmonary symptoms such as chest discomfort, shortness of breath, fatigue, and autonomic manifestations such as postural orthostatic tachycardia syndrome, and arrhythmias are prevalent and widely recognized. A variety of cardiovascular problems, including myocardial inflammation, myocardial infarction, ventricular dysfunction, and endothelial dysfunction, have been described in individuals following the initial acute phase. With over 10,000 published publications on COVID-19 and the cardiovascular system, presenting an unbiased thorough analysis of how SARSCoV-2 affects the system is essentially challenging. This review will provide an overview of frequent cardiovascular manifestations, emphasizing consequences, proposed pathophysiology, and clinical diagnostic manifestation strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID
- Author
-
Khoja O, Silva Passadouro B, Mulvey M, Delis I, Astill S, Tan AL, and Sivan M
- Subjects
post-covid-19 syndrome ,post-acute covid-19 ,chronic pain ,Medicine (General) ,R5-920 - Abstract
Omar Khoja,1,* Bárbara Silva Passadouro,1,* Matthew Mulvey,2 Ioannis Delis,3 Sarah Astill,3 Ai Lyn Tan,1,4 Manoj Sivan1,4,5 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; 2Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK; 3School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK; 4NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; 5COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK*These authors contributed equally to this workCorrespondence: Manoj Sivan, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Floor D Martin Wing, Leeds General Infirmary, Leeds, LS1 3EX, UK, Tel +44 113 3922564, Email M.Sivan@leeds.ac.ukObjective: Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The objective of this review is to identify and describe the features and characteristics of MSK pain in Long COVID patients.Methods: The narrative review involved a literature search of the following online databases: MEDLINE (OVID), EMBASE (OVID), CINAHL, PsyclNFO, and Web of Science (December 2019 to February 2022). We included observational studies that investigated the prevalence, characteristics, risk factors and mechanisms of MSK pain in Long COVID. After screening and reviewing the initial literature search results, a total of 35 studies were included in this review.Results: The overall reported prevalence of MSK pain in Long COVID ranged widely from 0.3% to 65.2%. The pain has been reported to be localized to a particular region or generalized and widespread. No consistent pattern of progression of MSK pain symptoms over time was identified. Female gender and higher BMI could be potential risk factors for Long COVID MSK pain, but no clear association has been found with age and ethnicity. Different pathophysiological mechanisms have been hypothesized to contribute to MSK pain in Long COVID including increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and MSK system cells, and psychological factors.Conclusion: MSK pain is one of the most common symptoms in Long COVID. Most of the current literature on Long COVID focuses on reporting the prevalence of persistent MSK pain. Studies describing the pain characteristics are scarce. The precise mechanism of MSK pain in Long COVID is yet to be investigated. Future research must explore the characteristics, risk factors, natural progression, and underlying mechanisms of MSK pain in Long COVID.Keywords: post-COVID-19 syndrome, post-acute COVID-19, chronic pain
- Published
- 2022
43. Delayed catastrophic thrombotic events in post-acute COVID-19.
- Author
-
Gupta, Abhinav, Satapathy, Ashis Kumar, and Bahinipati, Pravakar
- Subjects
- *
COVID-19 , *POST-acute COVID-19 syndrome , *PHYSICIANS , *HOSPITAL admission & discharge , *CRITICALLY ill , *THROMBOTIC thrombocytopenic purpura - Abstract
[Display omitted] • Thrombotic complications were previously recognized in critically ill COVID-19 patients in acute-phase. • We report thrombotic-events in asymptomatic/mild COVID-19 patients in home-based care & moderate/severe COVID-19 patients after discharge despite thromboprophylaxis during in-patient care. • Remarkably, thrombotic-events were delayed and occurred 30-76 days after diagnosis of COVID-19. • The estimated risk of post-discharge thrombosis of 1.8% per 100 patient-years as such doesn't warrant post-discharge thromboprophylaxis. • Physicians should remain vigilant and observe patients for thrombotic-events during post-acute phase, irrespective of severity of COVID-19 and absence of risk-factors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Chronic Endothelial Dysfunction after COVID-19 Infection Shown by Transcranial Color-Coded Doppler: A Cross-Sectional Study.
- Author
-
Marcic, Marino, Marcic, Ljiljana, Lovric Kojundzic, Sanja, Marinovic Guic, Maja, Marcic, Barbara, and Caljkusic, Kresimir
- Subjects
COVID-19 ,CROSS-sectional method ,FLOW velocity ,CEREBRAL arteries ,REST periods ,ENDOTHELIUM diseases - Abstract
In addition to respiratory symptoms, COVID-19 often causes damage to many other organs, especially in severe forms of the disease. Long-term consequences after COVID-19 are common and often have neurological symptoms. Cerebral vasoreactivity may be impaired after acute COVID-19 and in our study, we wanted to show how constant and reversible are the changes in brain vasoreactivity after infection. This cross-sectional observational study included 49 patients diagnosed with COVID-19 and mild neurological symptoms 300 days after the onset of the disease. We used a transcranial color-coded Doppler (TCCD) and a breath-holding test (BHT) to examine cerebral vasoreactivity and brain endothelial function. We analyzed the parameters of the flow rate through the middle cerebral artery (MCA): peak systolic velocity (PSV), end-diastolic velocity (EDV), mean velocity (MV), resistance index (RI) and pulsatility index (PI), and we calculated the breath-holding index (BHI). Subjects after COVID-19 infection had lower measured velocity parameters through MCA at rest period and after BHT, lower relative increases of flow velocities after BHT, and lower BHI. We showed that subjects, 300 days after COVID-19, still have impaired cerebral vasoreactivity measured by TCCD and they have chronic endothelial dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
45. Autoimmunity is a hallmark of post-COVID syndrome
- Author
-
Manuel Rojas, Yhojan Rodríguez, Yeny Acosta-Ampudia, Diana M. Monsalve, Chengsong Zhu, Quan-Zhen Li, Carolina Ramírez-Santana, and Juan-Manuel Anaya
- Subjects
Post-COVID syndrome ,Post-COVID ,Long COVID ,Post-acute COVID-19 ,COVID-19 ,Autoimmunity ,Medicine - Abstract
Abstract Autoimmunity has emerged as a characteristic of the post-COVID syndrome (PCS), which may be related to sex. In order to further investigate the relationship between SARS-CoV-2 and autoimmunity in PCS, a clinical and serological assessment on 100 patients was done. Serum antibody profiles against self-antigens and infectious agents were evaluated by an antigen array chip for 116 IgG and 104 IgM antibodies. Thirty pre-pandemic healthy individuals were included as a control group. The median age of patients was 49 years (IQR: 37.8 to 55.3). There were 47 males. The median post-COVID time was 219 (IQR: 143 to 258) days. Latent autoimmunity and polyautoimmunity were found in 83% and 62% of patients, respectively. Three patients developed an overt autoimmune disease. IgG antibodies against IL-2, CD8B, and thyroglobulin were found in more than 10% of the patients. Other IgG autoantibodies, such as anti-interferons, were positive in 5–10% of patients. Anti-SARS-CoV-2 IgG antibodies were found in > 85% of patients and were positively correlated with autoantibodies, age, and body mass index (BMI). Few autoantibodies were influenced by age and BMI. There was no effect of gender on the over- or under-expression of autoantibodies. IgG anti-IFN-λ antibodies were associated with the persistence of respiratory symptoms. In summary, autoimmunity is characteristic of PCS, and latent autoimmunity correlates with humoral response to SARS-CoV-2.
- Published
- 2022
- Full Text
- View/download PDF
46. Pattern of ophthalmic manifestations among COVID-19 survivors attending eye clinic in a tertiary care centre
- Author
-
Jasmita Satapathy, Alpana Mishra, Yamijala N Srija, Chinthala Navyasree, and Japesh Thareja
- Subjects
covid-19 survivors ,covid-recovered patients ,eye clinic ,ocular features ,post-acute covid-19 ,Ophthalmology ,RE1-994 - Abstract
Background: Almost every organ of the body including the eye can be affected in post-acute coronavirus disease 2019 (COVID-19) syndrome. Objective: To describe the pattern of ocular manifestations among recovered COVID-19 patients. Materials and Methods: An observational cross sectional study was conducted in the department of ophthalmology by recruiting patients who had recovered from COVID-19 and had attended eye clinic between 1 April 2021 and 30 June 2021. Comprehensive ophthalmological examination was performed in all participants. Results: A total 85 patients were enrolled (53 males and 32 females). Their mean age was 46.03 ± 16.2 years. The mean duration between positive real-time reverse transcription polymerase chain reaction test report for COVID-19 and the day of visit to eye clinic was 47.5±24.1 days. At least one ocular sign was present in 54 (63.5%) patients. The most common presenting ocular symptom was irritation (40%) followed by redness (29.4%). Frequently encountered ocular signs were conjunctival hyperaemia (37.6%), follicular conjunctivitis (30.6%), Keratoconjunctivitis (2.4%), central serous chorioretinopathy (3.5%), branch retinal vein occlusion (1.2%) and rhino-orbital mucormycosis (3.5%). Conclusion: Wide variety of ophthalmic manifestations can occur among COVID-19 survivors, some of which can also be sight threatening and hence they should not be ignored.
- Published
- 2022
- Full Text
- View/download PDF
47. Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation
- Author
-
Antonella Cecchetto, Gabriella Guarnieri, Gianpaolo Torreggiani, Andrea Vianello, Giulia Baroni, Chiara Palermo, Leonardo Bertagna De Marchi, Giulia Lorenzoni, Patrizia Bartolotta, Emanuele Bertaglia, Filippo Donato, Patrizia Aruta, Sabino Iliceto, and Donato Mele
- Subjects
dyspnea ,post-acute COVID-19 ,RVGLS ,RVGLS/sPAP ,respiratory muscle strength ,Medicine - Abstract
Post-acute COVID-19 is characterized by the persistence of dyspnea, but the pathophysiology is unclear. We evaluated the prevalence of dyspnea during follow-up and factors at admission and follow-up associated with dyspnea persistence. After five months from discharge, 225 consecutive patients hospitalized for moderate to severe COVID-19 pneumonia were assessed clinically and by laboratory tests, echocardiography, six-minute walking test (6MWT), and pulmonary function tests. Fifty-one patients reported persistent dyspnea. C-reactive protein (p = 0.025, OR 1.01 (95% CI 1.00–1.02)) at admission, longer duration of hospitalization (p = 0.005, OR 1.05 (95% CI 1.01–1.10)) and higher body mass index (p = 0.001, OR 1.15 (95% CI 1.06–1.28)) were independent predictors of dyspnea. Absolute drop in SpO2 at 6MWT (p = 0.001, OR 1.37 (95% CI 1.13–1.69)), right ventricular (RV) global longitudinal strain (p = 0.016, OR 1.12 (95% CI 1.02–1.25)) and RV global longitudinal strain/systolic pulmonary artery pressure ratio (p = 0.034, OR 0.14 (95% CI 0.02–0.86)) were independently associated with post-acute COVID-19 dyspnea. In conclusion, dyspnea is present in many patients during follow-up after hospitalization for COVID-19 pneumonia. While higher body mass index, C-reactive protein at admission, and duration of hospitalization are predictors of persistent dyspnea, desaturation at 6MWT, and echocardiographic RV dysfunction are associated with this symptom during the follow-up period.
- Published
- 2023
- Full Text
- View/download PDF
48. Evaluation of the Relationship between CRP/Albumin Ratio and Pulmonary Function Parameters in Patients with Post-Acute COVID-19.
- Author
-
Afsin, Dursun E. and Kerget, Bugra
- Subjects
COVID-19 ,ALBUMINS ,C-reactive protein ,SARS-CoV-2 ,VITAL capacity (Respiration) ,FORCED expiratory volume - Abstract
Background: Novel coronavirus disease 2019 (COVID-19), which has been a global pandemic for nearly 2 years, presents with highly variable clinical manifestations in both the acute and post-acute periods. This study evaluated the relationship between CRP/albumin ratio and pulmonary function at 12 weeks in patients with post-acute COVID-19. Methods: The study included 157 patients with a previous diagnosis of COVID-19 pneumonia who presented to our outpatient clinic with symptoms of post-acute COVID-19 (12 weeks after first testing positive) between July 2021 and October 2021. Patients who had non-severe pneumonia were included in group 1, severe pneumonia that did not require intensive care in group 2, and severe pneumonia that required intensive care in group 3. Results: At 12 weeks, group 3 had significantly lower percent predicted forced expiratory volume in 1 second (FEV1%), percent predicted forced vital capacity (FVC%), percent predicted diffusing capacity of the lungs for carbon monoxide (DLCO%), and oxygen saturation (SO2) compared to patients in groups 1 and 2 (p = 0.001, 0.04, 0.001, and 0.001, respectively). CRP/albumin ratio was significantly lower in group 2 compared to groups 1 and 3 (p = 0.001). Correlation analysis independent of age and comorbidity showed that CRP/albumin ratio was negatively correlated with SO2, FEV1%, FVC%, and DLCO%. Conclusions: CRP and albumin levels have prognostic significance during acute COVID-19 infection. The negative correlation between CRP/albumin ratio and respiratory function observed in our study suggest this parameter may be used in the follow-up of patients presenting at 12 weeks with post-acute COVID-19 symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. Assessment of SARS-CoV-2 Infection According to Previous Metabolic Status and Its Association with Mortality and Post-Acute COVID-19.
- Author
-
de Arriba Fernández, Alejandro, Alonso Bilbao, José Luis, Espiñeira Francés, Alberto, Cabeza Mora, Antonio, Gutiérrez Pérez, Ángela, Díaz Barreiros, Miguel Ángel, and Serra Majem, Lluís
- Abstract
Background. SARS-CoV-2 infection was analyzed according to previous metabolic status and its association with mortality and post-acute COVID-19. Methods. A population-based observational retrospective study was conducted on a cohort of 110,726 patients aged 12 years or more who were diagnosed with COVID-19 infection between June 1st, 2021, and 28 February 2022 on the island of Gran Canaria, Spain. Results. In the 347 patients who died, the combination of advanced age, male sex, cancer, immunosuppressive therapy, coronary heart disease, elevated total cholesterol and reduced high-density lipoprotein cholesterol (HDL-C) was strongly predictive of mortality (p < 0.05). In the 555 patients who developed post-acute COVID-19, the persistence of symptoms was most frequent in women, older subjects and patients with obstructive sleep apnea syndrome, asthma, elevated fasting glucose levels or elevated total cholesterol (p < 0.05). A complete vaccination schedule was associated with lower mortality (incidence rate ratio (IRR) 0.5, 95%CI 0.39–0.64; p < 0.05) and post-acute COVID-19 (IRR 0.37, 95%CI 0.31–0.44; p < 0.05). Conclusions. Elevated HDL-C and elevated total cholesterol were significantly associated with COVID-19 mortality. Elevated fasting glucose levels and elevated total cholesterol were risk factors for the development of post-acute COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
50. Is post-COVID syndrome an autoimmune disease?
- Author
-
Anaya, Juan-Manuel, Herrán, María, Beltrán, Santiago, and Rojas, Manuel
- Subjects
POST-acute COVID-19 syndrome ,AUTOIMMUNE diseases ,MEDICAL care ,COVID-19 pandemic ,ACUTE diseases - Abstract
Post-COVID syndrome (PCS) is recognized as a new entity in the context of SARS-CoV-2 infection. Though its pathogenesis is not completely understood, persistent inflammation from acute illness and the development of autoimmunity play a critical role in its development. The mechanisms involved in the emergence of PCS, their similarities with post-viral and post-care syndromes, its inclusion in the spectrum of autoimmunity and possible targets for its treatment. An autoimmune phenomenon plays a major role in most causative theories explaining PCS. There is a need for both PCS definition and classification criteria (including severity scores). Longitudinal and controlled studies are necessary to better understand this new entity, and to find what additional factors participate into its development. With the high prevalence of COVID-19 cases worldwide, together with the current evidence on latent autoimmunity in PCS, we may observe an increase of autoimmune diseases (ADs) in the coming years. Vaccination's effect on the development of PCS and ADs will also receive attention in the future. Health and social care services need to develop a new framework to deal with PCS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.